Sleep disturbances and insulin resistance

Diabetic Medicine

Volumn 28, Issue 12, 2011, Pages 1455-1462

  Van Cauter, E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Insulin resistance; Sleep apnoea

Indexed keywords

GLUCOSE; INSULIN; TESTOSTERONE;

APNEA HYPOPNEA INDEX; DIABETES MELLITUS; DIET RESTRICTION; DISEASE SEVERITY; HIRSUTISM; HUMAN; INSOMNIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MENSTRUAL IRREGULARITY; OBESITY; OVARY POLYCYSTIC DISEASE; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP QUALITY; TESTOSTERONE BLOOD LEVEL;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; POLYCYSTIC OVARY SYNDROME; POLYSOMNOGRAPHY; QUESTIONNAIRES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 81355154564     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03459.x     Document Type: Review

References (47)

1. Jean-Louis G, von Gizycki H, Zizi F, Spielman A, Hauri P, Taub H. The actigraph data analysis software: I. A novel approach to scoring and interpreting sleep-wake activity. Percept Mot Skills 1997; 85: 207-216.
2. Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11: 163-178.
3. National Center for Health Statistics. QuickStats: percentage of adults who reported an average of ≤6h of sleep per 24-h period, by sex and age group - United States, 1x985 and 2004. MMWR Morb Mortal Wkly Rep 2005; 54: 933.
4. Bonnet MH, Arand DL. Insomnia, metabolic rate and sleep restoration. J Intern Med 2003; 254: 23-31.
5. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metabol 2001; 86: 3787-3794.
6. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005; 99: 1592-1599.
7. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-1439.
8. Nedeltcheva AV, Kessler L, Imperial J, Penev PD. Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. J Clin Endocrinol Metab 2009; 94: 3242-3250.
9. Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1week reduces insulin sensitivity in healthy men. Diabetes 2010; 59: 2126-2133.
10. Leproult R, Van Cauter E. Role of sleep and sleep loss in hormonal release and metabolism. Endocr Dev 2010; 17: 11-21.
11. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003; 26: 380-384.
12. Bjorkelund C, Bondyr-Carlsson D, Lapidus L, Lissner L, Mansson J, Skoog I et al. Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. Diabetes Care 2005; 28: 2739-2744.
13. Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 2005; 28: 2762-2767.
14. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type2 diabetes. Diabetes Care 2006; 29: 657-661.
15. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs R, Kreier F, Pickering TG et al. Sleep duration as a risk factor for diabetes incidence in a large US sample. Sleep 2007; 30: 1667-1673.
16. Hayashino Y, Fukuhara S, Suzukamo Y, Okamura T, Tanaka T, Ueshima H. Relation between sleep quality and quantity, quality of life, and risk of developing diabetes in healthy workers in Japan: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. BMC Public Health 2007; 7: 129.
17. Chaput JP, Despres JP, Bouchard C, Astrup A, Tremblay A. Sleep duration as a risk factor for the development of type2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med 2009; 10: 919-924.
18. Beihl DA, Liese AD, Haffner SM. Sleep duration as a risk factor for incident type2 diabetes in a multiethnic cohort. Ann Epidemiol 2009; 19: 351-357.
19. Xu Q, Song Y, Hollenbeck A, Blair A, Schatzkin A, Chen H. Day napping and short night sleeping are associated with higher risk of diabetes in older adults. Diabetes Care 2010; 33: 78-83.
20. Rafalson L, Donahue RP, Stranges S, Lamonte MJ, Dmochowski J, Dorn J et al. Short sleep duration is associated with the development of impaired fasting glucose: the Western New York Health Study. Ann Epidemiol 20: 883-889.
21. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010; 33: 414-420.
22. Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab 2010; 24: 731-743.
23. Tasali E, Leproult R, Ehrmann DA, Van Cauter E. Slow-wave sleep and the risk of type2 diabetes in humans. Proc Natl Acad Sci U S A 2008; 105: 1044-1049.
24. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010; 137: 95-101.
25. Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Ostenson CG. Psychological distress and risk of pre-diabetes and Type2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med 2008; 25: 834-842.
26. Rod NH, Vahtera J, Westerlund H, Kivimaki M, Zins M, Goldberg M et al. Sleep disturbances and cause-specific mortality: results from the GAZEL cohort study. Am J Epidemiol 2010; 173: 300-309.
27. Suarez EC. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 2008; 22: 960-968.
28. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type2 diabetes: a population-based study. Diabetes Care 2009; 32: 1980-1985.
29. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552: 253-264.
30. O'Donnell CP. Metabolic consequences of intermittent hypoxia. Adv Exp Med Biol 2007; 618: 41-49.
31. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009; 106: 1538-1544.
32. Pamidi S, Aronsohn RS, Tasali E. Obstructive sleep apnea: role in the risk and severity of diabetes. Best Pract Res Clin Endocrinol Metab 2010; 24: 703-715.
33. Xu J, Long YS, Gozal D, Epstein PN. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med 2009; 46: 783-790.
34. Drager LF, Jun J, Polotsky VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2010; 17: 161-165.
35. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type2 diabetes: interacting epidemics. Chest 2008; 133: 496-506.
36. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005; 99: 1998-2007.
37. Levy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009; 34: 243-260.
38. Meslier N, Gagnadoux F, Giraud P, Person C, Ouksel H, Urban T et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003; 22: 156-160.
39. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160: 521-530.
40. Theorell-Haglow J, Berne C, Janson C, Lindberg E. Obstructive sleep apnoea is associated with decreased insulin sensitivity in females. Eur Respir J 2008; 31: 1054-1060.
41. Punjabi NM, Beamer BA. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 2009; 179: 235-240.
42. Nitsche K, Ehrmann DA. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2010; 24: 717-730.
43. Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 36-42.
44. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metabol 2001; 86: 517-520.
45. Tasali E, Van Cauter E, Hoffman L, Ehrmann DA. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 3878-3884.
46. Tasali E, Chapotot F, Leproult R, Whitmore H, Ehrmann DA. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2011; 96: 365-374.
47. Balkau B, Vol S, Loko S, Andriamboavonjy T, Lantieri O, Gusto G et al. High baseline insulin levels associated with 6-year incident observed sleep apnea. Diabetes Care 2010; 33: 1044-1049.